|
Market Closed -
Nasdaq
23:00:00 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 60.85 USD | -1.73% |
|
-0.75% | +57.48% |
| 08-13 | Zealand Pharma sells rusfertide rights for $100m | FW |
| 08-13 | Zealand Pharma to Sell Rusfertide-linked Economics to Royalty Pharma for $100 Million | MT |
| Market Cap | 27.1B 23.35B 21.89B 19.98B 37.65B 2,590B 37.77B 260B 101B 1,307B 102B 99.51B 4,334B | P/E 2026 * |
24.7x | P/E 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 36.21B 31.2B 29.25B 26.7B 50.3B 3,460B 50.46B 347B 135B 1,747B 136B 133B 5,792B | EV / Sales 2026 * |
10.4x | EV / Sales 2027 * | 9.53x |
| Free-Float |
72.41% | Yield 2026 * |
1.67% | Yield 2027 * | 1.75% |
Last Transcript : Royalty Pharma plc
| 1 day | -1.73% | ||
| 1 week | -0.75% | ||
| Current month | +4.14% | ||
| 1 month | +1.47% | ||
| 3 months | +11.69% | ||
| 6 months | +31.68% | ||
| Current year | +57.48% |
| 1 week | 60.66 |  | 62.46 |
| 1 month | 56.36 | | 62.46 |
| Current year | 38.29 | | 62.46 |
| 1 year | 34.08 | | 62.46 |
| 3 years | 24.05 | | 62.46 |
| 5 years | 24.05 | | 62.46 |
| 10 years | 24.05 | | 62.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 62 | 01/01/1996 |
Terrance Coyne
DFI | Director of Finance/CFO | 44 | 01/01/2010 |
Eric Schneider
CTO | Chief Tech/Sci/R&D Officer | - | 21/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Pablo Legorreta
CHM | Chairman | 62 | 01/04/2020 |
Gregory Norden
BRD | Director/Board Member | 68 | 11/02/2020 |
Bonnie Bassler
BRD | Director/Board Member | 63 | 16/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/19/26 A | Don | Executive/Senior Manager | -16,800 | 0.0038% | ||
| 8/13/26 A | Sell | Chief Financial Officer | -11,002 | 0.0025% | ||
| 8/7/26 A | Don | Chief Financial Officer | -18,500 | 0.0754% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.73% | -0.75% | +70.83% | +100.23% | 27.1B | |
| -0.13% | -6.44% | +60.47% | +112.05% | 1,047B | |
| +0.85% | -0.81% | +52.77% | +63.15% | 646B | |
| -1.03% | -3.58% | +22.87% | +73.29% | 451B | |
| -1.46% | -4.50% | +37.43% | +38.41% | 355B | |
| -0.72% | -2.89% | +21.86% | +36.79% | 291B | |
| -1.19% | -2.21% | +1.35% | +12.29% | 252B | |
| -1.05% | -1.57% | +51.40% | +68.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.29% | 203B | |
| -2.14% | -0.30% | +29.42% | +89.10% | 181B | |
| Average | -0.86% | -2.48% | +33.08% | +53.96% | 368.64B | |
| Weighted average by Cap. | -0.49% | -3.44% | +38.90% | +65.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.5B 3.01B 2.83B 2.58B 4.86B 334B 4.87B 33.52B 13.08B 169B 13.13B 12.84B 559B | 3.81B 3.28B 3.08B 2.81B 5.29B 364B 5.31B 36.52B 14.25B 184B 14.3B 13.99B 609B |
| Net income | 1.47B 1.27B 1.19B 1.08B 2.04B 140B 2.05B 14.09B 5.5B 70.92B 5.52B 5.4B 235B | 1.79B 1.55B 1.45B 1.32B 2.49B 171B 2.5B 17.2B 6.71B 86.57B 6.74B 6.59B 287B |
| Net Debt | 9.11B 7.85B 7.36B 6.72B 12.66B 871B 12.7B 87.33B 34.07B 440B 34.21B 33.46B 1,457B | 9.22B 7.94B 7.45B 6.8B 12.81B 881B 12.85B 88.37B 34.48B 445B 34.61B 33.86B 1,475B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | $60.85 | -1.73% | 1,701,316 |
| 27/08/26 | $61.92 | +0.19% | 2,094,005 |
| 26/08/26 | $61.80 | -0.43% | 1,478,067 |
| 25/08/26 | $62.07 | +1.21% | 1,705,153 |
| 24/08/26 | $61.33 | +0.03% | 2,357,873 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RPRX Stock
Select your edition
All financial news and data tailored to specific country editions
